Headache changes in individuals with migraine post-Covid-19: general characteristics of the acute phase and worsening of the migraine pattern

Authors

DOI:

https://doi.org/10.48208/HeadacheMed.2023.8

Keywords:

Headache, Migraine, COVID-19

Abstract

Introduction
The aim of this study was to investigate how infection with SARS-CoV-2 affected headache in individuals with migraine, and to identify characteristics associated with a worsening of the migraine post COVID-19.
Methods
Observational study composed of 157 individuals with migraine and who had been infected with the SARS-CoV-2 virus. They were recruited from the database of the headache research group at the Pontifical Catholic University of Paraná. The participants responded online to questions about their anthropometric data, history of infection with SARS-CoV-2, presence and characteristics of the headache in the acute phase, perception of a worsening of the migraine after infection, use of analgesics and prophylactic migraine medication. Validated digital questionnaires were used: Migraine Disability Assessment (MIDAS), Beck Depression Inventory (BDI) and Allodynia Symptom Checklist (ASC-12). The results of these questionnaires were compared to values previously recorded in the database, this information having been obtained prior to the infection with COVID-19.
Conclusion
Individuals who notice a worsening in migraine post-COVID-19 have a more severe migraine condition prior to infection, have more prominent headache during the acute phase and, subsequently, present with greater disability.

Downloads

Download data is not yet available.

Author Biographies

Aline Vitali da Silva, Professora de Medicina na Pontifícia Universidade Católica do Paraná

Neurologista, mestre, professora de medicina

Marianne Klock Peçanha, Pontifical Catholic University of Paraná, Londrina, Paraná, Brazil.

Acadêmica de Medicina

Amanda Pasquini de Freitas, Pontifical Catholic University of Paraná, Londrina, Paraná, Brazil.

Acadêmica de Medicina

Valéria Aparecida Bello, Pontifícia Universidade Católica do Paraná

Bióloga, Doutora em genética, professora de Medicina

Regina Célia Poli, Pontifícia Universidade Católica do Paraná

Bióloga, Doutora em genética, professora de medicina

References

Tana C, Bentivegna E, Cho S-J, Harriott AM, García-Azorín D, Labastida-Ramirez A, . . . Martelletti P. Long COVID headache. Journal Headache Pain 2022;23(1):93 Doi:10.1186/s10194-022-01450-8 DOI: https://doi.org/10.1186/s10194-022-01450-8

Garcia-Azorin D, Layos-Romero A, Porta-Etessam J, Membrilla JA, Caronna E, Gonzalez-Martinez A, . . . Pozo-Rosich P. Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients. Cephalalgia 2022;42(8):804-809 Doi:10.1177/03331024211068074 DOI: https://doi.org/10.1177/03331024211068074

Stovner LJ, Nichols E, Steiner TJ, Abd-Allah F, Abdelalim A, Al-Raddadi RM, . . . Murray CJL. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurol 2018;17(11):954-976 Doi:10.1016/s1474-4422(18)30322-3 DOI: https://doi.org/10.1016/S1474-4422(18)30322-3

Charles A. The pathophysiology of migraine: implications for clinical management. The Lancet Neurol 2018;17(2):174-182 Doi:10.1016/s1474-4422(17)30435-0 DOI: https://doi.org/10.1016/S1474-4422(17)30435-0

The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33(9):629-808 Doi:10.1177/0333102413485658 DOI: https://doi.org/10.1177/0333102413485658

Fragoso YD. MIDAS (Migraine Disability Assessment): a valuable tool for work-site identification of migraine in workers in Brazil. Sao Paulo Med J 2002;120(4):118-121 Doi:10.1590/s1516-31802002000400006 DOI: https://doi.org/10.1590/S1516-31802002000400006

Gomes-Oliveira MH, Gorenstein C, Neto FL, Andrade LH and Wang YP. Validation of the Brazilian Portuguese Version of the Beck Depression Inventory-II in a community sample. Rev Bras Psiquiatr 2012;34(4):389-394 Doi:10.1016/j.rbp.2012.03.005 DOI: https://doi.org/10.1016/j.rbp.2012.03.005

Florencio LL, Chaves TC, Branisso LB, Gonçalves MC, Dach F, Speciali JG, . . . Bevilaqua-Grossi D. 12 item Allodynia Symptom Checklist/Brasil: cross-cultural adaptation, internal consistency and reproducibility. Arq Neuro-Psiquiatr 2012;70(11):852-856 Doi:10.1590/s0004-282x2012001100006 DOI: https://doi.org/10.1590/S0004-282X2012001100006

Sampaio Rocha-Filho PA, Albuquerque PM, Carvalho LCLS, Dandara Pereira Gama M and Magalhães JE. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study. The J Headache Pain 2022;23(1):2 Doi:10.1186/s10194-021-01367-8 DOI: https://doi.org/10.1186/s10194-021-01367-8

Sampaio Rocha-Filho PA and Magalhães JE. Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia. Cephalalgia 2020;40(13):1443-1451 Doi:10.1177/0333102420966770 DOI: https://doi.org/10.1177/0333102420966770

Trigo López J, García-Azorín D, Planchuelo-Gómez Á, García-Iglesias C, Dueñas-Gutiérrez C and Guerrero ÁL. Phenotypic characterization of acute headache attributed to SARS-CoV-2: An ICHD-3 validation study on 106 hospitalized patients. Cephalalgia 2020;40(13):1432-1442 Doi:10.1177/0333102420965146 DOI: https://doi.org/10.1177/0333102420965146

Sampaio Rocha‐Filho PA. Headache associated with COVID‐19: Epidemiology, characteristics, pathophysiology, and management. Headache: The J Head Face Pain 2022;62(6):650-656 Doi:10.1111/head.14319 DOI: https://doi.org/10.1111/head.14319

Fernández-de-las-Peñas C, Gómez-Mayordomo V, Cuadrado ML, Palacios-Ceña D, Florencio LL, Guerrero AL, . . . Arendt-Nielsen L. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study. Cephalalgia 2021;41(13):1332-1341 Doi:10.1177/03331024211020404 DOI: https://doi.org/10.1177/03331024211020404

Dono F, Consoli S, Evangelista G, D’Apolito M, Russo M, Carrarini C, . . . Bonanni L. New daily persistent headache after SARS-CoV-2 infection: a report of two cases. Neurological Sciences 2021;42(10):3965-3968 Doi:10.1007/s10072-021-05444-3 DOI: https://doi.org/10.1007/s10072-021-05444-3

Caronna E, Alpuente A, Torres‐Ferrus M and Pozo‐Rosich P. Toward a better understanding of persistent headache after mild COVID‐19: Three migraine‐like yet distinct scenarios. Headache: The J Head Face Pain 2021;61(8):1277-1280 Doi:10.1111/head.14197 DOI: https://doi.org/10.1111/head.14197

Magdy R, Hussein M, Ragaie C, Abdel-Hamid HM, Khallaf A, Rizk HI and Dahshan A. Characteristics of headache attributed to COVID-19 infection and predictors of its frequency and intensity: A cross sectional study. Cephalalgia 2020;40(13):1422-1431 Doi:10.1177/0333102420965140 DOI: https://doi.org/10.1177/0333102420965140

Magdy R, Elmazny A, Soliman SH, Elsebaie EH, Ali SH, Abdel Fattah AM, . . . Hussein M. Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case–control study. The J Head Pain 2022;23(1):101 Doi:10.1186/s10194-022-01468-y DOI: https://doi.org/10.1186/s10194-022-01468-y

Downloads

Published

2023-03-31

How to Cite

1.
Silva AV da, Peçanha MK, Freitas AP de, Bello VA, Poli RC. Headache changes in individuals with migraine post-Covid-19: general characteristics of the acute phase and worsening of the migraine pattern. Headache Med [Internet]. 2023 Mar. 31 [cited 2024 May 6];14(1):36-42. Available from: https://headachemedicine.com.br/index.php/hm/article/view/753

Issue

Section

Original

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 > >>